Geneva was created in response to a need - a need to provide military medical researchers and clinicians with the resources necessary to improve the lives of our nation's service members and their families. In 1996, Elise Huszar, MBA joined Geneva as Executive Director and has served as President since 1998, and President & CEO since 2019. Since the beginning, Geneva has never lost sight of who we serve and how we serve.
The Fort Bragg Research Institute opens its first physical location at the Fayetteville Cumberland Economic Development Corporation’s CORE Innovation Center.
Geneva is awarded its first subaward from the U.S. Army Combat Capabilities Development Command, Chemical Biological Center (DEVCOM CBC) and prime ERP International to deliver Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE) research and development solutions to the warfighter.
Geneva is awarded a GSA Schedule under the Multiple Award Schedule (MAS), making it easier than ever before for Geneva to serve its federal customers.
The Biotechnology, Biomanufacturing, and Bioprinting Program (4D Bio3) is elevated by the Uniformed Services University to the USU-4D Bio3 Center for Biotechnology.
Geneva is awarded a subcontract under CRO Pharm-Olam for Operation Warp Speed to support two lead COVID-19 vaccine candidates at six military treatment facilities.
Geneva assumes management of the TriService Nursing Research Program at USU.
The USU issues a cooperative agreement to Geneva to facilitate the execution of the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) program.
Geneva opens its National Capital Region Office in Bethesda, MD.
Geneva celebrates its 25-year anniversary in service of its mission to advance military medicine.
The Uniformed Services University issues a cooperative agreement to Geneva to facilitate the execution of the 4D Biofabrication, Bioprinting, and Biomanufacturing (4DBio3) Program.
Geneva enters into a MOU with the Uniformed Services University to collaborate on multiple activities for the purpose of conducting medical research and education within the DoD and nationwide.
Geneva begins supporting pharmacy resident rotations at Naval Medical Center San Diego in partnership with University of California San Diego, and orthopaedic resident rotations at Madigan Army Medical Center and the VA Medical Center in San Francisco in partnership with Samuel Merritt University.
Geneva and the Jonas Center for Nursing and Veterans Healthcare establish a partnership aimed at supporting a doctoral nursing scholar to participate in military medical research with a focus on veteran needs.
Geneva is awarded its first Joint Warfighter Medical Research Program contract to support LTC Luis Alvarez at the National Cancer Institute – Frederick.
Geneva is awarded a contract from Naval Medical Logistics Command to support research efforts at Naval Medical Research Center – Frederick, including conducting joint research projects related to biodefense and/or infectious diseases with global research partners.
Lt. Col. Vikhyat Bebarta is selected as Geneva’s inaugural Researcher of the Year, in honor of his work to advance innovative medical research within the U.S. military.
The 2014 National Defense Authorization Act is signed into law, which includes language to officially extend privileges to Geneva in order to work directly with the Uniformed Services University.
Geneva’s growth leads to the formation of its Scientific Advisory Board to provide expert level research guidance, ethical review, and advocacy.
Geneva begins collaboration with the DoD Hearing Center of Excellence in the areas of research, professional, and administrative support services.
Geneva receives a Congressional Special Interest award to establish Centers for Targeted Radiation Therapy to treat cancer at Madigan Army Medical Center and the VA Puget Sound Health Care system.
Geneva supports first international study on the development of a Malaria vaccine at Armed Forces Research Institute of Medical Services in Thailand.
Geneva receives its first Congressionally Directed Medical Research Program to study new treatments for bone infection within critically wounded soldiers.
Geneva receives first National Institutes of Health awards at Walter Reed Army Institute of Research in the areas of respiratory toxicity and lung injury.
Geneva receives its first federal contract award to establish a Sponsored Research Office at Walter Reed Army Institute of Research.
Geneva begins providing formal proposal development services, creating a unique service not provided by similar non-profit organizations.
Geneva negotiates a master agreement for research and development with the U.S. Army, to advance military medical research.
Geneva commences its first multi-center consortium of research under the direction of Urology Service, Madigan Army Medical Center.
Geneva’s current President and CEO, Elise Huszar, is hired as its first Executive Director.
Geneva commences management of first federal grant award from TriService Nursing Research Program on behalf of nurse researchers at Madigan Army Medical Center.
Geneva is founded by Jane Taylor, a critical care nurse, to advance military medicine and to serve the research needs of Madigan Army Medical Center through industry-sponsored clinical trials, coordinating conferences, and administering preferred gifts of equipment and travel.